Skip to content

The correlation between heterogeneity and prognosis of primary Sjogren's syndrome: A prospective cohort study

The correlation between heterogeneity and prognosis of primary Sjogren's syndrome: A prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500103008
Enrollment
Unknown
Registered
2025-05-22
Start date
2025-05-31
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Sjögren's Syndrome

Interventions

Immune activation group:None
Dry Symptom group:None

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meet the classification criteria of primary Sjogren's syndrome; 2.Age >=18 years old and <=80 years old, gender not limited; 3.Understand and agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Coexisting with other autoimmune diseases; 2.Combined with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems; 3. Pregnant or lactating women; 4.Have a history of malignant tumors; 5.Hormones, immunosuppressants or biological agents have been used for treatment within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Disease improvement rate;

Secondary

MeasureTime frame
Disease progression rate;Disease stability rate;

Countries

China

Contacts

Public ContactLuan Xue

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

xelco@163.com+86 189 3056 8151

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026